Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An inherited metabolic disease affecting cobalamin (vitamin B12) intestinal absorption, transport in the blood, uptake by peripheral cells or cellular metabolism.
Biomarker and diagnostic research for inborn disorder of cobalamin metabolism and transport has been reported in the published literature.
3 clinical trials registered, 1 recruiting. Interventions under study include drug therapy, other interventions, and medical devices. Pipeline includes 1 PHASE4, 1 NA. Research is sponsored by a mix of industry and academic institutions.
110 publications have been identified in PubMed for inborn disorder of cobalamin metabolism and transport. Research spans Case Report / Case Series (34%), Review / Meta-Analysis (18%), and Epidemiology / Natural History (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 37 |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 12:37 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
34%
Research summaries | 20 | 18% |
Disease patterns and progression | 18 | 16% |
Laboratory research | 15 | 14% |
Testing and diagnosis research | 11 | 10% |
Clinical study results | 5 | 5% |
Other research | 2 | 2% |
New treatment approaches | 2 | 2% |
Stella M (2026). [PMID: 41787528](https://pubmed.ncbi.nlm.nih.gov/41787528/). *J Med Case Rep*. [Review / Meta-Analysis]
Matmat K (2026). [PMID: 41747718](https://pubmed.ncbi.nlm.nih.gov/41747718/). *Cell Rep Med*. [Basic Science / Preclinical]
Saini AG (2026). [PMID: 42158251](https://pubmed.ncbi.nlm.nih.gov/42158251/). *Front Nutr*. [Review / Meta-Analysis]
Schiavone FP (2026). [PMID: 41599884](https://pubmed.ncbi.nlm.nih.gov/41599884/). *Nutrients*. [Epidemiology / Natural History]
Caulfield S (2026). [PMID: 41742531](https://pubmed.ncbi.nlm.nih.gov/41742531/). *J Vet Intern Med*. [Basic Science / Preclinical]
Baldwin FD (2026). [PMID: 41537778](https://pubmed.ncbi.nlm.nih.gov/41537778/). *Diabetologia*. [Epidemiology / Natural History]
Vaqar S (2026). [PMID: 33760459](https://pubmed.ncbi.nlm.nih.gov/33760459/). *Unknown Journal*. [Clinical Trial Publication]
Witzig A (2026). [PMID: 41939647](https://pubmed.ncbi.nlm.nih.gov/41939647/). *Cureus*. [Case Report / Case Series]
Bjørke-Monsen AL (2026). [PMID: 41683246](https://pubmed.ncbi.nlm.nih.gov/41683246/). *Nutrients*. [Epidemiology / Natural History]
Park M (2026). [PMID: 42132356](https://pubmed.ncbi.nlm.nih.gov/42132356/). *J Vet Intern Med*. [Basic Science / Preclinical]